Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.97B |
| 2 |
Microsoft
MSFT
|
+$1.32B |
| 3 |
Amgen
AMGN
|
+$1.09B |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$443M |
| 5 |
TSMC
TSM
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$993M |
| 2 |
CERN
Cerner Corp
CERN
|
+$863M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$586M |
| 4 |
AT&T
T
|
+$373M |
| 5 |
COHR
Coherent Inc
COHR
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Healthcare | 9.3% |
| 3 | Financials | 8.52% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Industrials | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CEVA Inc
CEVA
$1.01B
| $5.74M | ﹤0.01% |
171,041
+60,634
| +55% | +$2.14M |
|
2952
National Healthcare
NHC
$3.48B
| $5.74M | ﹤0.01% |
82,059
+13,521
| +20% | +$947K |
|
2953
PUT
Biogen
BIIB
$29.8B
| $5.73M | ﹤0.01% |
28,100
| – | – |
|
2954
Cohen & Steers
CNS
$4.35B
| $5.73M | ﹤0.01% |
90,106
-1,213
| -1% | -$91.7K |
|
2955
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$516M
| $5.72M | ﹤0.01% |
+109,479
| New | +$5.85M |
|
2956
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.9B
| $5.71M | ﹤0.01% |
65,400
-137,800
| -68% | -$13M |
|
2957
American Vanguard Corp
AVD
$70.4M
| $5.71M | ﹤0.01% |
255,499
+192,970
| +309% | +$4.32M |
|
2958
Alerus Financial
ALRS
$853M
| $5.71M | ﹤0.01% |
239,800
-64,085
| -21% | -$1.63M |
|
|
SMLR
2959
DELISTED
Semler Scientific
SMLR
| $5.7M | ﹤0.01% |
202,236
-25,293
| -11% | -$904K |
|
|
SEDA
2960
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
| $5.7M | ﹤0.01% |
584,550
| – | – |
|
2961
Aclaris Therapeutics
ACRS
$772M
| $5.69M | ﹤0.01% |
407,889
+149,430
| +58% | +$2.09M |
|
2962
CAE Inc. Common Shares
CAE
$8.51B
| $5.69M | ﹤0.01% |
231,075
-231,713
| -50% | -$5.74M |
|
2963
DHT Holdings
DHT
$2.98B
| $5.69M | ﹤0.01% |
927,734
+525,341
| +131% | +$3.09M |
|
2964
CALL
Moderna
MRNA
$22.8B
| $5.68M | ﹤0.01% |
39,800
-107,000
| -73% | -$15.3M |
|
2965
PUT
CSX Corp
CSX
$94.5B
| $5.68M | ﹤0.01% |
195,500
+145,500
| +291% | +$4.74M |
|
2966
iShares US Pharmaceuticals ETF
IHE
$1.62B
| $5.67M | ﹤0.01% |
88,782
+63,825
| +256% | +$4.05M |
|
2967
iShares Core MSCI Total International Stock ETF
IXUS
$59.6B
| $5.66M | ﹤0.01% |
99,320
-1,535
| -2% | -$94.5K |
|
|
MDC
2968
DELISTED
M.D.C. Holdings, Inc.
MDC
| $5.66M | ﹤0.01% |
175,167
+7,290
| +4% | +$261K |
|
2969
iShares MSCI Intl Value Factor ETF
IVLU
$4.5B
| $5.66M | ﹤0.01% |
255,028
+46,951
| +23% | +$1.14M |
|
2970
Artivion
AORT
$1.33B
| $5.65M | ﹤0.01% |
299,348
+40,815
| +16% | +$787K |
|
|
KZR
2971
DELISTED
Kezar Life Sciences
KZR
| $5.64M | ﹤0.01% |
68,257
+42,337
| +163% | +$3.73M |
|
|
VMEO
2972
DELISTED
Vimeo
VMEO
| $5.63M | ﹤0.01% |
935,938
+420,493
| +82% | +$3.81M |
|
2973
Chunghwa Telecom
CHT
$32.9B
| $5.62M | ﹤0.01% |
136,203
-27,270
| -17% | -$1.17M |
|
2974
PUT
Ecolab
ECL
$79.7B
| $5.61M | ﹤0.01% |
+36,500
| New | +$6.05M |
|
|
ZUO
2975
DELISTED
Zuora, Inc.
ZUO
| $5.61M | ﹤0.01% |
627,016
+41,621
| +7% | +$462K |
|
Similar funds
Goldman Sachs's Q2 2022 Portfolio in Review
As of Q2 2022, Goldman Sachs held 6,980 positions worth $400B, down 16% from $476B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs's Q2 2022 filing shows 409 new, 2,565 increased, 2,533 reduced and 543 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M. The largest sale was Invesco QQQ Trust, an estimated $993M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- Goldman Sachs's largest Q2 2022 buy was iShares US Treasury Bond ETF: 6,205,288 shares worth $148M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $2.97B increase.
- Goldman Sachs's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $993M.
- Goldman Sachs fully exited Cerner Corp in Q2 2022, selling an estimated $863M.
- Goldman Sachs's ten largest holdings make up 18% of its $400B portfolio in Q2 2022.
- Goldman Sachs opened 409 new positions and closed 543 in Q2 2022.
- Goldman Sachs's portfolio value fell 16% quarter-over-quarter to $400B.
Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.